• Placeholder


Facts of INLYTA (Axitinib) Tablets ?

  • Medicine Name: INLYTA
  • Generic Name: Axitinib
  • Approval Date: 09/06/2013
  • Company Name: Pfizer
  • Available as (Form & Strength): 1 mg and 5 mg tablets

Product Description

What are the indications and usage?

INLYTA is indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.

How supplied/storage and handling ?

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].


There are no reviews yet.

Be the first to review “Inlyta”